project id: TCGA-ACC; case submitter id: TCGA-OR-A5LA; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.26; rna integrity number: 7.1; age at index: 52; days to birth: -19242; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1960; age at diagnosis: 19242; ajcc clinical m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 719.0; icd 10 code: C74.0; last known disease status: not reported; morphology: 8370/3; primary diagnosis: Adrenal cortical carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cortex of adrenal gland; synchronous malignancy: No; tissue or organ of origin: Cortex of adrenal gland; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 208; initial weight: 60.0; sample id: b3447e85-1d34-4fb0-8f08-03b9ea98fa0a; sample submitter id: TCGA-OR-A5LA-01A; portion id: 725732a3-0dda-4076-8f0c-699a7db96b1f; portion submitter id: TCGA-OR-A5LA-01A-11; slide id: 309eb684-5588-440e-a14e-0f0e50237c95; slide submitter id: TCGA-OR-A5LA-01A-01-TS1; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 10.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0; section location: TOP;